SULF2 antibody

Contáctenos para saber el precio
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
SULF2 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab08375
tested applications
ELISA, WB, IHC
Description
Exhibits arylsulfatase activity and highly specific endoglucosamine-6-sulfatase activity. It can remove sulfate from the C-6 position of glucosamine within specific subregions of intact heparin.
Documents del producto
Product specifications
Category | Primary Antibodies |
Immunogen Target | sulfatase 2 (SULF2) |
Host | Rabbit |
Reactivity | Human, Mouse, Rat |
Recommended Dilution | WB: 1:500-1:2000; IHC: 1:20-1:200 |
Clonality | polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Observed MW | 130-150 kDa |
Purity | ≥95% as determined by SDS-PAGE |
Purification | Immunogen affinity purified |
Size 1 | 100µg |
Form | liquid |
Tested Applications | ELISA, WB, IHC |
Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
UniProt ID | Q8IWU5 |
Gene ID | 55959 |
Alias | Extracellular sulfatase Sulf-2 (hSulf-2),Arylsulfatase,N-acetylglucosamine-6-sulfatase,Extracellular sulfatase Sulf-2 secreted form,SULF2,KIAA1247 |
Background | Antibody anti-SULF2 |
Status | RUO |
Note | Mol. Weight 130-150 kDa |
Descripción
Related Products

Human SULF2 (Extracellular sulfatase Sulf-2) ELISA Kit
Ver Producto
SULF2 antibody
Exhibits arylsulfatase activity and highly specific endoglucosamine-6-sulfatase activity. It can remove sulfate from the C-6 position of glucosamine within specific subregions of intact heparin.
Ver Producto
Sulfatase 2 (SULF2) Antibody
Heparan sulfate proteoglycans (HSPGs) act as coreceptors for numerous heparin-binding growth factors and cytokines and are involved in cell signaling. Heparan sulfate 6-O-endosulfatases, such as SULF2, selectively remove 6-O-sulfate groups from heparan sulfate. This activity modulates the effects of heparan sulfate by altering binding sites for signaling molecules (Dai et al., 2005 [PubMed 16192265]).
Ver Producto